HK2 depletion was found to inhibit glycolysis and induce oxidative phosphorylation in HCC.[25] In our study, we used an in vivo CRISPR/Cas9 knockout screen to identify HK2 as an oncogenic candidate for HCC, which was consistent with the results from previous studies. Here, HK2 is linked to hepatocellular carcinoma.